Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients

Measles, mumps and rubella (MMR) still determine significant morbidity and mortality, although a highly effective vaccine is available. Postponing the MMR vaccination until 6 months after the last red blood cell (RBC) transfusion is recommended, but this delay is incompatible with chronic transfusio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Vaccines (Basel)
Päätekijät: Casale, Maddalena, Di Maio, Nicoletta, Verde, Valentina, Scianguetta, Saverio, Di Girolamo, Maria Grazia, Tomeo, Rita, Roberti, Domenico, Misso, Saverio, Perrotta, Silverio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8227230/
https://ncbi.nlm.nih.gov/pubmed/34072263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060561
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia